InvestorsHub Logo
Followers 16
Posts 2238
Boards Moderated 0
Alias Born 06/22/2010

Re: BTH post# 9049

Tuesday, 06/07/2011 1:36:25 PM

Tuesday, June 07, 2011 1:36:25 PM

Post# of 80490
I don't think they can run a trial designed to address needs of patients that have developed a resistance or mutation to a drug that isn't yet approved. I would think right now they would have to run it against the current standard of care. I could be way off base here.....
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.